184 related articles for article (PubMed ID: 17275176)
21. Regulation of DNA repair in hypoxic cancer cells.
Bindra RS; Crosby ME; Glazer PM
Cancer Metastasis Rev; 2007 Jun; 26(2):249-60. PubMed ID: 17415527
[TBL] [Abstract][Full Text] [Related]
22. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
23. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract][Full Text] [Related]
24. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
Lawes DA; Pearson T; Sengupta S; Boulos PB
Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
[TBL] [Abstract][Full Text] [Related]
25. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.
Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A
J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306
[TBL] [Abstract][Full Text] [Related]
26. Defects of DNA mismatch repair in human prostate cancer.
Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
[TBL] [Abstract][Full Text] [Related]
28. DNA mismatch repair initiates 6-thioguanine--induced autophagy through p53 activation in human tumor cells.
Zeng X; Yan T; Schupp JE; Seo Y; Kinsella TJ
Clin Cancer Res; 2007 Feb; 13(4):1315-21. PubMed ID: 17317843
[TBL] [Abstract][Full Text] [Related]
29. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
[TBL] [Abstract][Full Text] [Related]
30. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
Si J; Yu X; Zhang Y; DeWille JW
Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
[TBL] [Abstract][Full Text] [Related]
31. MCM9 Is Required for Mammalian DNA Mismatch Repair.
Traver S; Coulombe P; Peiffer I; Hutchins JR; Kitzmann M; Latreille D; Méchali M
Mol Cell; 2015 Sep; 59(5):831-9. PubMed ID: 26300262
[TBL] [Abstract][Full Text] [Related]
32. Preferential loss of mismatch repair function in refractory and relapsed acute myeloid leukemia: potential contribution to AML progression.
Mao G; Yuan F; Absher K; Jennings CD; Howard DS; Jordan CT; Gu L
Cell Res; 2008 Feb; 18(2):281-9. PubMed ID: 18227862
[TBL] [Abstract][Full Text] [Related]
33. DNA mismatch repair proteins are required for efficient herpes simplex virus 1 replication.
Mohni KN; Mastrocola AS; Bai P; Weller SK; Heinen CD
J Virol; 2011 Dec; 85(23):12241-53. PubMed ID: 21957315
[TBL] [Abstract][Full Text] [Related]
34. Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.
Sawant A; Kothandapani A; Zhitkovich A; Sobol RW; Patrick SM
DNA Repair (Amst); 2015 Nov; 35():126-36. PubMed ID: 26519826
[TBL] [Abstract][Full Text] [Related]
35. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
37. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
[TBL] [Abstract][Full Text] [Related]
38. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
[TBL] [Abstract][Full Text] [Related]
39. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer.
Cesinaro AM; Ubiali A; Sighinolfi P; Trentini GP; Gentili F; Facchetti F
Am J Dermatopathol; 2007 Aug; 29(4):351-8. PubMed ID: 17667167
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer.
Ewald J; Rodrigue CM; Mourra N; Lefèvre JH; Fléjou JF; Tiret E; Gespach C; Parc YR
Br J Surg; 2007 Aug; 94(8):1020-7. PubMed ID: 17440950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
